These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 30022821)
1. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma. Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821 [TBL] [Abstract][Full Text] [Related]
2. Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment. Liu S; Han X; Liu H; Zhao Y; Li H; D Rupenthal I; Lv Z; Chen Y; Yang F; Ping Q; Pan Y; Hou D Drug Deliv; 2020 Dec; 27(1):652-661. PubMed ID: 32347126 [TBL] [Abstract][Full Text] [Related]
3. Controlled drug delivery for glaucoma therapy using montmorillonite/Eudragit microspheres as an ion-exchange carrier. Tian S; Li J; Tao Q; Zhao Y; Lv Z; Yang F; Duan H; Chen Y; Zhou Q; Hou D Int J Nanomedicine; 2018; 13():415-428. PubMed ID: 29391798 [TBL] [Abstract][Full Text] [Related]
4. A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride. Huang Y; Tao Q; Hou D; Hu S; Tian S; Chen Y; Gui R; Yang L; Wang Y Int J Nanomedicine; 2017; 12():1731-1745. PubMed ID: 28280338 [TBL] [Abstract][Full Text] [Related]
5. Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction. Hu J; Li H; Zhao Y; Ke Y; Rupenthal ID; Liu H; Ye J; Han X; Yang F; Li W; Lin H; Hou D Int J Nanomedicine; 2022; 17():5915-5931. PubMed ID: 36506343 [TBL] [Abstract][Full Text] [Related]
6. Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy. Jain K; Kumar RS; Sood S; Dhyanandhan G Curr Drug Deliv; 2013 Oct; 10(5):493-9. PubMed ID: 23410069 [TBL] [Abstract][Full Text] [Related]
7. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496 [TBL] [Abstract][Full Text] [Related]
8. Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres. Liu H; Han X; Li H; Tao Q; Hu J; Liu S; Liu H; Zhou J; Li W; Yang F; Ping Q; Wei S; Liu H; Lin H; Hou D Drug Deliv; 2021 Dec; 28(1):2011-2023. PubMed ID: 34569888 [TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits. Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326 [TBL] [Abstract][Full Text] [Related]
10. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery. Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726 [TBL] [Abstract][Full Text] [Related]
11. Combination of self-assembling system and N,O-carboxymethyl chitosan improves ocular residence of anti-glaucoma drug. Kailasam V; Kumara BN; Prasad KS; Nirmal J Eur J Pharm Biopharm; 2024 Apr; 197():114208. PubMed ID: 38336235 [TBL] [Abstract][Full Text] [Related]
12. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study. Dubey V; Mohan P; Dangi JS; Kesavan K Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741 [TBL] [Abstract][Full Text] [Related]
13. Preparation, pharmacokinetics and pharmacodynamics of ophthalmic thermosensitive in situ hydrogel of betaxolol hydrochloride. Huang W; Zhang N; Hua H; Liu T; Tang Y; Fu L; Yang Y; Ma X; Zhao Y Biomed Pharmacother; 2016 Oct; 83():107-113. PubMed ID: 27470557 [TBL] [Abstract][Full Text] [Related]
14. Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone. Ban J; Zhang Y; Huang X; Deng G; Hou D; Chen Y; Lu Z Int J Nanomedicine; 2017; 12():1329-1339. PubMed ID: 28243093 [TBL] [Abstract][Full Text] [Related]
15. Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: Radwan SE; El-Moslemany RM; Mehanna RA; Thabet EH; Abdelfattah EA; El-Kamel A Drug Deliv; 2022 Dec; 29(1):1150-1163. PubMed ID: 35384774 [TBL] [Abstract][Full Text] [Related]
16. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
17. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment. Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551 [TBL] [Abstract][Full Text] [Related]
18. Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment. Cheng YH; Tsai TH; Jhan YY; Chiu AW; Tsai KL; Chien CS; Chiou SH; Liu CJ Carbohydr Polym; 2016 Jun; 144():390-9. PubMed ID: 27083831 [TBL] [Abstract][Full Text] [Related]
19. Chitosan based nanocarriers for indomethacin ocular delivery. Badawi AA; El-Laithy HM; El Qidra RK; El Mofty H; El dally M Arch Pharm Res; 2008 Aug; 31(8):1040-9. PubMed ID: 18787795 [TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma. Maulvi FA; Patel AR; Shetty KH; Desai DT; Shah DO; Willcox MDP Drug Deliv Transl Res; 2024 Nov; 14(11):3212-3224. PubMed ID: 38407770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]